American Society of Clinical Oncology articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/12/19 09:08
2014/12/19 09:08
3d
Professors Stanton McHardy and Rong Li will lead collaborative research team Stanton McHardy, associate professor of chemistry and director of the Center for Innovative Drug Discovery (CIDD) in The...
2014/12/19 09:08
2014/12/19 09:08
Latest videos
2014/12/18 14:12
2014/12/18 14:12
4d
By Staff WriterHudson sues Akron over water issues DOWNTOWN AKRON — A difference of opinion on water charges set by Akron for its City of Hudson customers has resulted in a lawsuit. The City of...
2014/12/16 22:17
2014/12/16 22:17
5d
... as Somatuline®) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or...
2014/12/14 16:52
2014/12/14 16:52
8d
... go at the end, I guess." Doctors now get some training in school in delivering bad news. The American Society of Clinical Oncology (ASCO) is working to integrate palliative care - which focuses...
2014/12/12 22:45
2014/12/12 22:45
9d
... economic or work-related hardships, according to a study released in October by the American Society of Clinical Oncology. What’s perhaps most troubling though, is how these...
2014/12/11 11:08
2014/12/11 11:08
11d
Findings reveal slow adoption of patient-preferred and less costly hypofractionated radiation therapy Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation...
2014/12/10 17:25
2014/12/10 17:25
12d
... that knowledge into practice, a study finds. And one reason is that the doctors in charge of radiation treatment will make less money, according to Dr. Ezekiel Emanuel, a study author and a...
2014/12/10 01:02
2014/12/10 01:02
12d
Nansea Gratz pulled off her fleece beanie, the kind with little ears, revealing wisps of gray hair on an otherwise bald head. She removed her fuzzy pink socks and asked an attentive massage therapist...
2014/12/09 13:08
2014/12/09 13:08
13d
Novartis today announced data from the largest clinical trial of myelofibrosis patients treated with Jakavi® (ruxolitinib), supporting the safety profile and efficacy benefit as measured in primary...
2014/12/09 09:08
2014/12/09 09:08
13d
... therapy when used with rituximab. Data suggest that the overall efficacy and safety profile of IMBRUVICA is well tolerated when combined with rituximab in patients with relapsed or...
2014/12/09 06:09
2014/12/09 06:09
13d
... 2014 - 11:42pm A University clinical director will serve as the next president of the American Society of Clinical Oncology, a professional organization comprising more than 35,000...
2014/12/08 17:17
2014/12/08 17:17
14d
... lymphoid malignancies Available for logged-in reporters onlyCitations56th Annual Meeting of the American Society of Hematology (ASH) annual conference Newswise — Study results of...
2014/12/08 16:31
2014/12/08 16:31
14d
FRANCISCO, Dec. 8, 2014 /PRNewswire-USNewswire/ -- As researchers attending the 2014 American Society of Hematology (ASH) Annual Meeting & Exposition discuss the latest medical...
2014/12/08 15:55
2014/12/08 15:55
14d
... failed to respond to other treatments showed improvement in studies that tested the effect of two PD-1 inhibitors - immunotherapy drugs that help the immune system recognize and attack...
2014/12/08 09:02
2014/12/08 09:02
14d
Last week, I discussed a monograph published in the Journal of the National Cancer Institute Monographs entitled Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in...
2014/12/08 07:17
2014/12/08 07:17
14d
... that develops innovative “tumor starvation” treatments for acute leukemia and other oncology indications with unmet medical needs, reports additional positive Phase III results from...
2014/12/08 07:08
2014/12/08 07:08
14d
AbbVie (NYSE: ABBV) presented during an oral presentation at the American Society of Hematology's 56th Annual Meeting new results from a Phase 2 study of investigational compound venetoclax...
2014/12/08 05:17
2014/12/08 05:17
14d
WIRE)--Nordic Nanovector presented late Sunday evening (US PST) in a poster session at the 56th American Society of Hematology (ASH) Annual Meeting in San Francisco, CA the data from the phase I...
2014/12/06 18:17
2014/12/06 18:17
16d
... KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, achieved an overall response rate of 66 percent, as assessed by International Harmonization Project response criteria (n=19/29: 95%...
2014/12/05 13:17
2014/12/05 13:17
17d
WIRE)--RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the formation of the RainDance HemOnc Consortium,...
2014/12/19 09:08
2014/12/19 09:08
Latest from Twitter